China Money Network
Login
Join

Chinese New Drug Development Firm TargetRx Raises $21M In Series A Round

  • May 4, 2020 — 17:06 CST

This Data Is Locked!

This area is available only to Subscribers.

TargetRx, Shenzhen-based innovative drug development company, recently announced that it has completed a RMB150 million (US$21.2 million) Series A round financing, led by CCB Principal... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: